reboxetine在欧洲和40多个国家有广泛的安全性记录，在这些国家被批准用于治疗抑郁症。 AXS-12在发作性睡病中的作用得到了积极的临床前和2期临床 ...

reboxetine在欧洲和40多个国家有广泛的安全性记录，在这些国家被批准用于治疗抑郁症。 AXS-12在发作性睡病中的作用得到了临床前和初步临床结果的 ...

Neuropsychopharmacology - Influence of Reboxetine on Salivary MHPG Concentration and Cognitive Symptoms Among Patients with Alcohol-Related Korsakoff's Syndrome. Skip to main content.

One week of treatment with combination reboxetine 4 mg plus oxybutynin 5 mg resulted in decreased severity of obstructive sleep apnea, according to new data published in Chest.Previously, studies ...

Pfizer Inc.’s antidepressant reboxetine, sold for more than a decade in Europe, is no more effective than a placebo at treating symptoms of depression, according to an analysis that included ...

According to a new study, an antidepressant prescribed over the last 13 years is ineffective and potentially harmful. The drug in question is called Reboxetine and is available under the name of ...

There is no scientific proof that people suffering from depression can benefit from taking reboxetine. However, clinical trials do provide proof of benefit of bupropion XL and mirtazapine. This is ...

Review the side-effects of Reboxetine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

How to Take Reboxetine and it's Dose. Written by - Dhanalakshmi Chinnuswamy, Diploma in Pharmacy, MBA (Healthcare) Medically Checked by - S. Hemamalini, B. Pharm. Last Updated on August 11, 2022 .

BioWorld Content on 'Reboxetine' Pfizer Inc. was a swinging door today as it sold its small molecule for treating patients with behavioral and neurological symptoms to Biogen Inc., while licensing ...